MORGAN DUKE: Open Payments
NPI 1093280331 · OPELIKA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 68 payments from 9 companies in 2025. Trend: 2023 $492 · 2024 $992 · 2025 $1,034
Food & beverage: $1,034
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 28 | $279 |
| ABBVIE INC. | 21 | $260 |
| ACADIA Pharmaceuticals Inc | 5 | $184 |
| Biogen, Inc. | 4 | $88 |
| Axsome Therapeutics, Inc. | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| Eisai Inc. | 1 | $23 |
| ARGENX US, INC. | 1 | $21 |
Products named: NURTEC ODT, UBRELVY, NUPLAZID, Symbravo, LEQEMBI, KESIMPTA, BOTOX, TYSABRI.
Industry payments across AL — which companies pay providers there.
